CN107778229A - A kind of preparation method of the formonitrile HCN of 7 halo, 6 nitro, 1,4 EEDQ, 4 ketone 3 - Google Patents

A kind of preparation method of the formonitrile HCN of 7 halo, 6 nitro, 1,4 EEDQ, 4 ketone 3 Download PDF

Info

Publication number
CN107778229A
CN107778229A CN201711025493.4A CN201711025493A CN107778229A CN 107778229 A CN107778229 A CN 107778229A CN 201711025493 A CN201711025493 A CN 201711025493A CN 107778229 A CN107778229 A CN 107778229A
Authority
CN
China
Prior art keywords
ketone
halo
eedq
isosorbide
acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201711025493.4A
Other languages
Chinese (zh)
Inventor
周章涛
叶伟平
费安杰
黄志宁
樊彤彤
吴桂宝
肖诗华
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Raffles Guangdong Pharmaceutical Technology Co Ltd
Original Assignee
Raffles Guangdong Pharmaceutical Technology Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Raffles Guangdong Pharmaceutical Technology Co Ltd filed Critical Raffles Guangdong Pharmaceutical Technology Co Ltd
Priority to CN201711025493.4A priority Critical patent/CN107778229A/en
Publication of CN107778229A publication Critical patent/CN107778229A/en
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/54Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
    • C07D215/56Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3 with oxygen atoms in position 4

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

Abstract

The invention discloses a kind of nitro 1 of 7 halo 6, the preparation method of the formonitrile HCN of 4 EEDQ, 4 ketone 3, comprises the following steps, S1, using the halogen benzoic acid of 2 amino 4 as initiation material, under catalyst action, the esterification generation Aminobenzoate of 4 halo 2 is carried out with simple fatty alcohol;S2, the Aminobenzoate of 4 halo 2 react under acidic catalyst with 3 dimethylaminopropionitriles, generate 4 halo 2 ((2 acrylonitrile base) amino) benzoic ethers;S3, the cyclization under highly basic effect of ((the 2 acrylonitrile base) amino) benzoic ether of 4 halo 2, obtain the formonitrile HCN of 74 ketone of halo Isosorbide-5-Nitrae EEDQ 3;S4, the formonitrile HCN of 74 ketone of halo Isosorbide-5-Nitrae EEDQ 3 are nitrified in the presence of the nitration mixture of strong acid and nitric acid, obtain the formonitrile HCN of 7 halo, 64 ketone of nitro Isosorbide-5-Nitrae EEDQ 3;Process route is novel, obtains the intermediate of novelty, and total recovery is more than 35%, has the characteristics that process route is novel, reaction condition is relatively mild.

Description

A kind of preparation method of 7- halos -6- nitros -1,4- EEDQ -4- ketone -3- formonitrile HCNs
Technical field
The present invention relates to organic chemical synthesis field, more particularly, to a kind of 7- halos -6- nitros-Isosorbide-5-Nitrae-dihydro quinoline The preparation method of quinoline -4- ketone -3- formonitrile HCNs.
Background technology
Before having a various clinical, clinical phase and listing new drug contain 6,7- bis- and substitute -4- substitution -3- formonitrile HCN fragments.Following institute Show three types drug molecule, and marketed drug such as HKI-272(Neratinib), clinical the second stage of medicine Pelitinib, Contain the important feature fragment.
This structure piece has two main synthetic routes at present, and its high temperature cyclization route is as follows.This route Major defect be that ring closure reaction needs 250 degree or sos of high temperature, in general pharmaceutical equipment is difficult to reach, it is also difficult to which progress is safely Ground production amplification:
Another synthetic method is following synthetic route.This synthetic route is relatively excellent, and the reagent used is relatively inexpensive, reacts bar Part is more gentle.
But during this two lines synthesis object construction fragment, the substituent of 7 is fixed as alkoxy, is sieved to high flux The diversity of the substituent of required compound brings very big challenge when selecting, and it is other substituents that can not particularly synthesize 7 The compound of type.
If, can be by flexible using 7- halos -6- nitro-Isosorbide-5-Nitrae-EEDQ -4- ketone -3- formonitrile HCNs as intermediate Change nucleophilic displacement of fluorine base Nu1 and Nu2, the problem of adequate solution molecular structure of compounds diversity to be synthesized is bad.
However, 7- halos -6- nitro-Isosorbide-5-Nitrae-EEDQ -4- ketone -3- first nitrile compounds take high temperature cyclization at present Method is synthesized, and the synthesis and production amplification to this kind of compound bring great difficulty.
In summary, the development need 7- halos -6- nitro-Isosorbide-5-Nitrae-EEDQ -4- ketone -3- formonitrile HCNs of pharmaceutical industry this Class medicine intermediate, but there are severe reaction conditions in its process route, material security is low, is difficult to the characteristics of production amplification.
The content of the invention
In view of the shortcomings of the prior art, it is anti-to improve preparation 7- halos -6- nitro-Isosorbide-5-Nitrae-EEDQ -4- ketone -3- formonitrile HCNs Answer that condition is harsh, process safety is low, is difficult to the problems such as production amplification, the invention provides a kind of 7- halos -6- nitro-Isosorbide-5-Nitraes - The preparation method of EEDQ -4- ketone -3- formonitrile HCNs.
The present invention is realized by the following technical programs:
A kind of preparation method of 7- halos -6- nitros-Isosorbide-5-Nitrae-EEDQ -4- ketone -3- formonitrile HCNs, comprises the following steps,
S1, using 2- amino -4- halogen benzoic acids as initiation material, under catalyst action, esterification life is carried out with simple fatty alcohol Into 4- halo -2- Aminobenzoates;
S2,4- halo -2- Aminobenzoates react under acidic catalyst with 3- dimethylaminopropionitriles, and generation 4- halos - 2- ((2- acrylonitriles base) amino) benzoic ether;
The cyclization under highly basic effect of S3,4- halo -2- ((2- acrylonitriles base) amino) benzoic ethers, obtains 7- halos-Isosorbide-5-Nitrae-two Hydrogen quinoline -4- ketone -3- formonitrile HCNs;
S4,7- halo-Isosorbide-5-Nitrae-EEDQ -4- ketone -3- formonitrile HCNs are nitrified in the presence of the nitration mixture of strong acid and nitric acid, obtain 7- Halo -6- nitro -1,4- EEDQ -4- ketone -3- formonitrile HCNs;
Synthetic route is as follows:
Wherein, X is fluorine, chlorine, bromine or iodine;R is methyl, ethyl, isopropyl, n-propyl, normal-butyl or isobutyl group.
Further, R is preferably methyl.
Further, in step S1, the catalyst is the concentrated sulfuric acid, thionyl chloride, POCl3 or dicyclohexyl carbon two One kind in imines.
Further, in step S1, the catalyst is preferably the concentrated sulfuric acid.
Further, in step S2, the acidic catalyst is in trifluoroacetic acid, acetic acid, methanesulfonic acid or p-methyl benzenesulfonic acid One kind.
Further, in step S2, the acidic catalyst is preferably acetic acid.
Further, in step S3, the highly basic is DBU, TBD, MTBD, potassium tert-butoxide, butyl lithium, caustic alcohol, methanol One kind in sodium, hexamethl disilamine base lithium, tert-butyl lithium or isobutyl group lithium.
Further, in step S3, the highly basic is preferably tert-butyl lithium.
Further, in step S4, the strong acid be the concentrated sulfuric acid, chlorosulfonic acid, methanesulfonic acid, polyphosphoric acids, trifluoromethanesulfonic acid, One kind in trifluoromethanesulfanhydride anhydride or TFAA.
Further, in step S4, the strong acid is preferably polyphosphoric acids.
Compared with prior art, the invention has the advantages that:
1st, 7- halos -6- nitro-Isosorbide-5-Nitrae-EEDQ -4- ketone -3- formonitrile HCNs, process route are prepared using the synthetic route of the present invention Novelty, the intermediate of novelty is obtained, total recovery is more than 35%, has the characteristics that process route is novel, reaction condition is relatively mild.
2nd, technique is easy to get using raw material, and cost is relatively low, no special operational process, not high to equipment requirement, is adapted to industrialization Production.
Embodiment
Presently preferred embodiments of the present invention is described in detail below, so that advantages and features of the invention are more easy to by this area skill Art personnel understand, so as to make apparent define to protection scope of the present invention.
Embodiment 1
1st, the synthesis of 2- amino -4- chloro benzoic ethers
Single port bottle adds 10g 2- amino -4- chlorobenzoic acids, 150ml methanol, is cooled to 0-5 DEG C, 10.4g dichloros are added dropwise in insulation Sulfoxide.It is added dropwise, temperature rising reflux reaction 24hrs.Room temperature is dropped to, is concentrated under reduced pressure and removes methanol.Addition 100ml ethyl acetate, The sodium carbonate liquors of 100ml 5%, stirring, stand, separate water layer, organic layer is washed with 100ml, is depressurized after anhydrous sodium sulfate drying It is concentrated to give 2- amino -4- chloro benzoic ether 8.9g, yield 82%.
2nd, the synthesis of the chloro- 2- of 4- ((2- acrylonitriles base) amino) methyl benzoate
Add 10g 2- amino -4- chloro benzoic ethers in single port bottle, 80ml ethyl acetate, 10ml trifluoroacetic acids, be then added dropwise 6.2g 3- dimethylaminopropionitriles, 2-3hrs is reacted at room temperature, separate out yellow solid, filtering, a small amount of ethyl acetate washing, vacuum Dry, obtain the chloro- 2- of 10.1g 4- ((2- acrylonitriles base) amino) methyl benzoate, yield 79%.
3rd, the synthesis of the chloro- 1,4- EEDQs -4- ketone -3- formonitrile HCNs of 7-
10g 4- chloro- 2- ((2- acrylonitriles base) amino) methyl benzoate is added in there-necked flask, 150ml THF, is cooled to -78 DEG C, 51ml tert-butyl lithiums are added dropwise(1.9mol pentane solution).It is added dropwise, insulation reaction 1h, 7.6g is then slowly added dropwise Acetic acid.Room temperature is raised to, is filtered, vacuum drying, obtains the chloro- Isosorbide-5-Nitraes of 6.5g 7--EEDQ -4- ketone -3- formonitrile HCNs, yield 75%.
4th, the synthesis of the chloro- 6- nitros -1,4- EEDQs -4- ketone -3- formonitrile HCNs of 7-
The chloro- Isosorbide-5-Nitraes of 10 g 7--EEDQ -4- ketone -3- formonitrile HCNs, 30ml trifluoromethanesulfanhydride anhydrides, nitrogen protection are added in there-necked flask Under be cooled to 0 DEG C, 5ml concentrated nitric acids are added dropwise in insulation, insulation reaction 1h, then control less than 10 DEG C dropwise addition 40ml water of temperature.Insulation 1h is stirred, filtering, a small amount of washing, vacuum drying, obtains the chloro- 6- nitros-Isosorbide-5-Nitrae-EEDQ -4- ketone -3- formonitrile HCNs of 9.2g 7-, Yield 75%.
The synthetic route total recovery of the chloro- 6- nitros -1,4- EEDQs -4- ketone -3- formonitrile HCNs of 7- is 36.4%.
Embodiment 2
1st, the synthesis of 2- amino -4- methyl-bromobenzoates
Single port bottle adds 10g 2- amino -4- bromobenzoic acids, 150ml methanol, the 10ml concentrated sulfuric acids, heating reflux reaction 24hrs.Drop To room temperature, it is concentrated under reduced pressure and removes methanol.Add 100ml ethyl acetate, the sodium carbonate liquors of 100ml 5%, stir 5mins after it is quiet Layering is put, separates water layer, organic layer is washed with 100ml, and 2- amino -4- bromobenzene first is concentrated under reduced pressure to give after anhydrous sodium sulfate drying Sour methyl esters 9.16g, yield 86%.
2nd, the synthesis of the bromo- 2- of 4- ((2- acrylonitriles base) amino) methyl benzoate
Add 10g 2- amino -4- methyl-bromobenzoates in single port bottle, 60ml ethyl acetate, 6.0g 3- dimethylaminos are then added dropwise Acrylonitrile, 3-4hrs is reacted at room temperature, 60ml water is added dropwise, 2hrs is then stirred at room temperature, filtered, a small amount of water washing, vacuum drying, obtained To the bromo- 2- of 10.39g 4- ((2- acrylonitriles base) amino) methyl benzoate, yield 85%.
3rd, the synthesis of the bromo- 1,4- EEDQs -4- ketone -3- formonitrile HCNs of 7-
10g 4- bromo- 2- ((2- acrylonitriles base) amino) methyl benzoate is added in single port bottle, 150ml absolute ethyl alcohols, is added dropwise 16.3g 28% sodium methoxide solution.It is added dropwise, temperature rising reflux reaction 1h, 7.6g acetic acid is then slowly added dropwise.Drop to room temperature, mistake Filter, a small amount of ethanol washing, vacuum drying, obtains the bromo- Isosorbide-5-Nitraes of 7.09g 7--EEDQ -4- ketone -3- formonitrile HCNs, yield 80%.
4th, the synthesis of the bromo- 6- nitros -1,4- EEDQs -4- ketone -3- formonitrile HCNs of 7-
The 40ml concentrated sulfuric acids are added in there-necked flask, are cooled to 0 DEG C, then add the bromo- Isosorbide-5-Nitraes of 10g 7--EEDQ -4- ketone -3- first 5ml concentrated nitric acids are slowly added dropwise in nitrile, insulation.It is added dropwise, insulation reaction 30mins.Then reaction solution is poured into 200ml frozen water In, after stirring 20mins, filter, wash, vacuum drying, obtain the bromo- 6- nitros-Isosorbide-5-Nitrae-EEDQ -4- ketone -3- of 9.56g 7- Formonitrile HCN, yield 81%.
The synthetic route total recovery of the bromo- 6- nitros -1,4- EEDQs -4- ketone -3- formonitrile HCNs of 7- is 47.4%.
The preferred embodiments of the present invention are these are only, are not intended to limit the scope of the invention, it is every to utilize this hair The equivalent structure or equivalent flow conversion that bright specification is made, or other related technical areas are directly or indirectly used in, Similarly it is included within the scope of the present invention.

Claims (5)

  1. A kind of 1. preparation method of 7- halos -6- nitros-Isosorbide-5-Nitrae-EEDQ -4- ketone -3- formonitrile HCNs, it is characterised in that:Including with Lower step,
    S1, using 2- amino -4- halogen benzoic acids as initiation material, under catalyst action, esterification life is carried out with simple fatty alcohol Into 4- halo -2- Aminobenzoates;
    S2,4- halo -2- Aminobenzoates react under acidic catalyst with 3- dimethylaminopropionitriles, and generation 4- halos - 2- ((2- acrylonitriles base) amino) benzoic ether;
    The cyclization under highly basic effect of S3,4- halo -2- ((2- acrylonitriles base) amino) benzoic ethers, obtains 7- halos-Isosorbide-5-Nitrae-two Hydrogen quinoline -4- ketone -3- formonitrile HCNs;
    S4,7- halo-Isosorbide-5-Nitrae-EEDQ -4- ketone -3- formonitrile HCNs are nitrified in the presence of the nitration mixture of strong acid and nitric acid, obtain 7- Halo -6- nitro -1,4- EEDQ -4- ketone -3- formonitrile HCNs;
    Synthetic route is as follows:
    Wherein, X is fluorine, chlorine, bromine or iodine;R is methyl, ethyl, isopropyl, n-propyl, normal-butyl or isobutyl group.
  2. 2. the preparation method of 7- halos -6- nitros-Isosorbide-5-Nitrae-EEDQ -4- ketone -3- formonitrile HCNs according to claim 1, its It is characterised by:In step S1, the catalyst is in the concentrated sulfuric acid, thionyl chloride, POCl3 or dicyclohexylcarbodiimide It is a kind of.
  3. 3. the preparation method of 7- halos -6- nitros-Isosorbide-5-Nitrae-EEDQ -4- ketone -3- formonitrile HCNs according to claim 1, its It is characterised by:In step S2, the acidic catalyst is one kind in trifluoroacetic acid, acetic acid, methanesulfonic acid or p-methyl benzenesulfonic acid.
  4. 4. the preparation method of 7- halos -6- nitros-Isosorbide-5-Nitrae-EEDQ -4- ketone -3- formonitrile HCNs according to claim 1, its It is characterised by:In step S3, the highly basic is DBU, TBD, MTBD, potassium tert-butoxide, butyl lithium, caustic alcohol, sodium methoxide, hexamethyl One kind in two silicon lithium amides, tert-butyl lithium or isobutyl group lithium.
  5. 5. the preparation method of 7- halos -6- nitros-Isosorbide-5-Nitrae-EEDQ -4- ketone -3- formonitrile HCNs according to claim 1, its It is characterised by:In step S4, the strong acid is the concentrated sulfuric acid, chlorosulfonic acid, methanesulfonic acid, polyphosphoric acids, trifluoromethanesulfonic acid, fluoroform sulphur One kind in acid anhydrides or TFAA.
CN201711025493.4A 2017-10-27 2017-10-27 A kind of preparation method of the formonitrile HCN of 7 halo, 6 nitro, 1,4 EEDQ, 4 ketone 3 Pending CN107778229A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201711025493.4A CN107778229A (en) 2017-10-27 2017-10-27 A kind of preparation method of the formonitrile HCN of 7 halo, 6 nitro, 1,4 EEDQ, 4 ketone 3

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201711025493.4A CN107778229A (en) 2017-10-27 2017-10-27 A kind of preparation method of the formonitrile HCN of 7 halo, 6 nitro, 1,4 EEDQ, 4 ketone 3

Publications (1)

Publication Number Publication Date
CN107778229A true CN107778229A (en) 2018-03-09

Family

ID=61432048

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201711025493.4A Pending CN107778229A (en) 2017-10-27 2017-10-27 A kind of preparation method of the formonitrile HCN of 7 halo, 6 nitro, 1,4 EEDQ, 4 ketone 3

Country Status (1)

Country Link
CN (1) CN107778229A (en)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6297258B1 (en) * 1998-09-29 2001-10-02 American Cyanamid Company Substituted 3-cyanoquinolines
CN1704404A (en) * 1999-12-29 2005-12-07 惠氏公司 Tricyclic protein kinase inhibitors
CN104774184A (en) * 2015-04-17 2015-07-15 中国药科大学 Alpha-cyano-alpha, beta-unsaturated amide compound and medical application thereof
CN106243046A (en) * 2016-08-02 2016-12-21 南京工业大学 A kind of preparation method of mesosulfuron

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6297258B1 (en) * 1998-09-29 2001-10-02 American Cyanamid Company Substituted 3-cyanoquinolines
CN1704404A (en) * 1999-12-29 2005-12-07 惠氏公司 Tricyclic protein kinase inhibitors
CN104774184A (en) * 2015-04-17 2015-07-15 中国药科大学 Alpha-cyano-alpha, beta-unsaturated amide compound and medical application thereof
CN106243046A (en) * 2016-08-02 2016-12-21 南京工业大学 A kind of preparation method of mesosulfuron

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
ALEXANDER L. RUCHELMAN ET AL.: "Nitro and amino substitution within the A-ring of 5H-8,9-dimethoxy-5-(2-N,N-dimethylaminoethyl)dibenzo[c,h][1,6]-naphthyridin-6-ones: influence on topoisomerase I-targeting activity and cytotoxicity", 《BIOORGANIC & MEDICINAL CHEMISTRY》 *

Similar Documents

Publication Publication Date Title
ES2384368T3 (en) Process for preparing derivatives of 1- (2-halobiphenyl-4-yl) -cyclopropanecarboxylic acid
CN101863880B (en) Fasudil hydrochloride compound and novel method thereof
CN106279047B (en) A kind of preparation method of prostacyclin receptor agonist
CN103772243A (en) Preparation method of mesotrione
CN104513223B (en) The preparation method of fluorenes ethanone derivatives
CN111747921A (en) Preparation method and medical application of daphnetin derivative
CN102942509A (en) Synthetic method of etamsylate
CN108530355B (en) A kind of synthetic method of 3- [2- (the chloro- 2- quinolyl of 7-) vinyl] benzaldehyde
CN104370935B (en) A kind of preparation method of bisulfate clopidogrel
CN107778229A (en) A kind of preparation method of the formonitrile HCN of 7 halo, 6 nitro, 1,4 EEDQ, 4 ketone 3
WO2023174449A1 (en) Method for preparing n-(3-chloro-4-(2-pyridylmethoxy)phenyl)-2-cyanoacetamide
CN105622538A (en) One-pot high-yielding preparation of cetilistat
CN105037059B (en) A kind of α(4 substituted-phenyls)Isobutyric preparation method
CN103193666B (en) The preparation method of 2-amino-3-chloro benzoic ether
CN105503668B (en) A kind of synthetic method of 4 chlorine 2 (N methyl N phenyl sulfamic) methyl benzoates
CN101260069A (en) Method for preparing nimesulide intermediate 2-phenoxymethanesulphonylaniline
CN108929217A (en) A kind of preparation method of 2- methyl -5- fluobenzoic acid
WO2021258979A1 (en) Preparation method for aromatic ether compound
CN107629039B (en) The preparation method and intermediate of deuterated acrylamide
CN107021968B (en) The method of the polysubstituted organic photochemical catalyst catalyzing indole quinoline class compound oxidation dehydrogenation synthesis of indole class compound of BODIPY
CN103360270B (en) Serine derived chiral amine compound as well as preparation method and application thereof
JP2001335571A (en) Method for producing phthalic anhydride
CN105348197A (en) Preparation method of lorcaserin hydrochloride
CN106748884B (en) Preparation method of bicalutamide intermediate
CN104230926A (en) Preparation method of minodronic acid key intermediate

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20180309